CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 180 filers reported holding CHEMOCENTRYX INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $13,518,000 | +82.0% | 545,532 | +84.1% | 5.54% | +90.7% |
| Q1 2022 | $7,429,000 | -53.2% | 296,327 | -32.1% | 2.90% | -53.6% |
| Q4 2021 | $15,886,000 | +217.7% | 436,300 | +49.2% | 6.25% | +214.7% |
| Q3 2021 | $5,000,000 | -51.4% | 292,445 | +76.1% | 1.99% | -46.8% |
| Q4 2020 | $10,283,000 | – | 166,077 | – | 3.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |